IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Date	Title
08/12/2008	Acomplia (08 Dec)
02/12/2008	Prograf & Advagraf (tacrolimus)-Important Safety Information from Astellas Pharma following approval by the IMB
28/11/2008	Drug Substance Section of Dossiers - A Regulators view
19/11/2008	Lucentis (ranibizumab)-Important Safety Information from Novartis following approval by the IMB
07/11/2008	MabThera (rituximab)-Important Safety Information from Roche on rituximab and PML, following approval by the IMB
06/11/2008	Guide to Batch-Specific Requests for Human Medicines
05/11/2008	IMB Newsletter Issue No. 30 April - August 2008
04/11/2008	Raptiva (efalizumab)-Important Safety Information from Merck Serono on the association of efalizumab with PML
24/10/2008	Acomplia (rimonabant)-Important Safety Information from Sanofi Aventis concerning the suspension of Acomplia
03/10/2008	Perfalgan (paracetamol)-Important Safety Notice from Bristol-Myers Squibb regarding hepatic toxicity
30/09/2008	Arcoxia (etoricoxib)-Important Safety Information from Merck Sharp & Dohme following approval by the IMB
22/09/2008	Relistor (methylnaltrexone bromide)-Important Safety Information from Wyeth as approved by the IMB
17/09/2008	Drug Safety Newsletter 28th Edition
01/09/2008	Volume 9A of The Rules Governing Medicinal Products in the European Union
18/08/2008	Tysabri (natalizumab)-Important Safety Information from Elan/Biogen Idec as approved by the IMB
01/08/2008	Thalidomide Pharmion-Important Safety Information from Celgene as approved by the IMB
28/07/2008	Dostinex (cabergoline)-Important Safety Information from Pfizer as approved by the IMB
28/07/2008	Cabaser (cabergoline)-Important Safety Information from Pfizer as approved by the IMB
21/07/2008	Celance (pergolide)-Important Safety Information from Lilly as approved by the IMB
16/07/2008	Humira (adalimumab)-Important Safety Information from Abbott Laboratories as approved by the IMB